Results 151 to 160 of about 26,196,167 (310)

Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy. [PDF]

Mol Oncol, 2023
Prasad K, Cross RS, Jenkins MR.
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Traffic congestion remains a perennial problem in the capital city, causing waste of hundreds of hours in the streets. How to address the terrible problem? [PDF]

, 2015
New Age
core  

Subclinical Kwashiorkor in Adults: A New Age Paradigm. [PDF]

Indian J Endocrinol Metab, 2022
Kapoor N, Bhattacharya S, Agarwal N, Das S, Bantwal G, Deshmukh V, Kalra S.   +6 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Art show held at BRACU [PDF]

, 2016
New Age
core  

RNA vaccines: The dawn of a new age for tuberculosis? [PDF]

Hum Vaccin Immunother
Li J, Liu D, Li X, Wei J, Du W, Zhao A, Xu M.   +6 more
europepmc   +1 more source

Electronic textiles: New age of wearable technology for healthcare and fitness solutions. [PDF]

Mater Today Bio, 2023
Meena JS, Choi SB, Jung SB, Kim JW.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Assessing ChatGPT's Capability as a New Age Standardized Patient: Qualitative Study. [PDF]

JMIR Med Educ
Cross J, Kayalackakom T, Robinson RE, Vaughans A, Sebastian R, Hood R, Lewis C, Devaraju S, Honnavar P, Naik S, Joseph J, Anand N, Mohammed A, Johnson A, Cohen E, Adeniji T, Nnenna Nnaji A, George JE.   +17 more
europepmc   +1 more source